Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong, Suideng Qin, Lunzhi Dai, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 166

Showing 1-25 of 166 citing articles:

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
SARS-CoV-2 Drug Resistance and Therapeutic Approaches
Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41980-e41980
Open Access | Times Cited: 3
Architects of infection: A structural overview of SARS-related coronavirus spike glycoproteins
Francesca R. Hills, Jemma L. Geoghegan, Mihnea Bostina
Virology (2025), pp. 110383-110383
Open Access | Times Cited: 1
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Jialing Yin, Chengcheng Li, Chunhong Ye, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 824-837
Open Access | Times Cited: 64
Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics
Maddy L. Newby, Carl A. Fogarty, Joel D. Allen, et al.
Journal of Molecular Biology (2022) Vol. 435, Iss. 4, pp. 167928-167928
Open Access | Times Cited: 44
Strategies for Glycoengineering Therapeutic Proteins
Kris Dammen‐Brower, Paige Epler, Stanley Zhu, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 39
Carbon nanotubes and nanobelts as potential materials for biosensor
Seyyed Mostafa Monavari, Farah Marsusi, Nafiseh Memarian, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Protein post-translational modification in SARS-CoV-2 and host interaction
Nana Cheng, Mingzhu Liu, Wanting Li, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 26
Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
Life Science Alliance (2024) Vol. 7, Iss. 5, pp. e202302453-e202302453
Open Access | Times Cited: 8
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 214-226
Open Access | Times Cited: 8
Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A
Maja Klevanski, Heeyoung Kim, Mike Heilemann, et al.
Antiviral Research (2024) Vol. 225, pp. 105856-105856
Open Access | Times Cited: 7
COVID‐19 metabolism: Mechanisms and therapeutic targets
Tianshi Wang, Ying Cao, Haiyan Zhang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence
Anna Riccio, Silvia Santopolo, Antonio Rossi, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 5
Open Access | Times Cited: 29
O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern
Edgar González-Rodríguez, Mia Zol-Hanlon, Ganka Bineva‐Todd, et al.
ACS Central Science (2023) Vol. 9, Iss. 3, pp. 393-404
Open Access | Times Cited: 19
Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants
Yongjing Xie, Michael Butler
Glycobiology (2023) Vol. 33, Iss. 3, pp. 188-202
Open Access | Times Cited: 15
N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease
Chiranjeevi Pasala, Sahil Sharma, Tanaya Roychowdhury, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 282-282
Open Access | Times Cited: 5
A comprehensive analysis of SARS-CoV-2 missense mutations indicates that all possible amino acid replacements in the viral proteins occurred within the first two-and-a-half years of the pandemic
Nicole Balasco, Gianluca Damaggio, Luciana Esposito, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131054-131054
Open Access | Times Cited: 5
The essential role of prebiotics in restoring gut health in long COVID
Alberto Rubio‐Casillas, César Manuel Rodríguez-Quintero, Altijana Hromić-Jahjefendić, et al.
Progress in molecular biology and translational science (2025)
Closed Access
Impact of African-Specific ACE2 Polymorphisms on Omicron BA.4/5 RBD Binding and Allosteric Communication Within the ACE2–RBD Protein Complex
Victor Barozi, Özlem Taştan Bishop
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1367-1367
Open Access
Exploring the effects of N234 and N343 linked glycans to SARS CoV 2 spike protein pocket accessibility using Gaussian accelerated molecular dynamics simulations
Ronny L. Cheng, James Peter L. Lim, M. Fortuna, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Production and intracellular trafficking of SARS CoV-2 spike protein in insect cells infected with recombinant baculovirus
Merve Simsar, Erkan Rayaman, Elif Çağlayan, et al.
Journal of Research in Pharmacy (2025) Vol. 29, Iss. 1, pp. 65-74
Open Access
Rational Development of Hypervalent Glycan Shield‐Binding Nanoparticles with Broad‐Spectrum Inhibition against Fatal Viruses Including SARS‐CoV‐2 Variants
Ying Li, Shuxin Xu, Qing Ye, et al.
Advanced Science (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 22
SARS‐CoV‐2 ORF3a expression in brain disrupts the autophagy–lysosomal pathway, impairs sphingolipid homeostasis, and drives neuropathogenesis
Hongling Zhu, Colleen Byrnes, Y Terry Lee, et al.
The FASEB Journal (2023) Vol. 37, Iss. 5
Open Access | Times Cited: 14
Analysis of the N-glycosylation profiles of the spike proteins from the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2
Dongxia Wang, Jakub Baudys, Sarah H. Osman, et al.
Analytical and Bioanalytical Chemistry (2023) Vol. 415, Iss. 19, pp. 4779-4793
Open Access | Times Cited: 14
Blood-brain barrier function in response to SARS-CoV-2 and its spike protein
Łukasz Suprewicz, Krzysztof Fiedoruk, Agata Czarnowska, et al.
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 14-25
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top